The Medicines and Healthcare products Regulatory Agency (MHRA) issued a recall yesterday (July 10) of all batches of valsartan/hydrochlorothiazide 160/12.5mg film-coated tablets – used to treat high blood pressure and heart conditions – made by Accord Healthcare.
The alert comes after the watchdog issued a recall last week (July 6) for seven batches of valsartan-containing medicines made by Accord Healthcare and Dexcel Pharma Ltd, after an impurity was identified in their manufacturing process which “may have carcinogenic potential”.
“An investigation into other potentially impacted products is currently being undertaken and further updates will be provided as the investigation progresses,” the MHRA said.
Advice for pharmacies
The MHRA has advised pharmacies to stop supplying the product immediately, and to quarantine all remaining stock and return it to the supplier.
“If you receive queries about this issue from patients, encourage them not to stop taking their medication,” the watchdog added.